An ecological analysis of incidence of tuberculosis and per capita gross domestic product.

REFERENCES 1 Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 2007; 30: 623–626. 2 Migliori GB, Lange C, Centis R, et al. Resistance to secondline injectables and treatment outcomes in multidrugresistant and extensively drug-resistant tuberculosis cases. Eur Respir J 2008; 31: 1155–1159. 3 World Health Organization. The global MDR-TB & XDRTB response plan 2007-2008. Geneva, World Health Organization, 2007. 4 Raviglione MC, Smith IM. XDR tuberculosis – implications for global public health. N Engl J Med 2007; 356: 656–659. 5 Gandhi NR, Moll A, Sturm AW, et al. Extensively drugresistant tuberculosis as a cause of death in patients coinfected with tuberculosis in a rural area of South Africa. Lancet 2006; 368: 1575–1580. 6 Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000–2004. Morb Mortal Wkly Rep 2006; 55: 301–305. 7 Jeon CY. Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcome among patients at a tertiary referral hospital. Clin Infect Dis 2008; 46: 42–49. 8 Tousek J, Jancik E, Zelenka M, Jancikova-Máková M. The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS, a five-year follow-up. Tubercle 1967; 48: 27–31. 9 Zierski M, Zachara A. Late results in re-treatment of patients with pulmonary tuberculosis. Tubercle 1970; 51: 172–177. 10 Somner AR, Brace AA. Late results of treatment of chronic drug-resistant pulmonary tuberculosis. BMJ 1966; 1: 775–778. 11 Fischer DA, Lester W, Dye WE, Moulding TS. Re-treatment of patients with isoniazid-resistant tuberculosis. Analysis and follow-up of 146 cases. Am Rev Respir Dis 1968; 97: 392–398. 12 Kass I. Chemotherapy regimens used in retreatment ofpulmonary tuberculosis. I. Observations on the efficacy of combinations of kanamycin, ethionamide and either cycloserine or pyrazinamide. Tubercle 1965; 46: 151–165. 13 Pines A. Treatment of pulmonary tuberculosis with cultures resistant to two or more drugs: a series of 44 patients. Tubercle 1965; 46: 131–142. 14 Kass I. Chemotherapy regiments used in retreatment of pulmonary tuberculosis. II. Observations on the efficacy of combinations of ethambutol, capreomycin and companion drugs, including 4-4 diisoamyloxythiosemicarbanilide. Tubercle 1965; 46: 166–177. 15 Caminero JA. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006; 10: 829–837.